The Cancer Letter

Inside information on cancer research and drug development

Guest Editorial

“Do no harm” must guide social media for healthcare professionals

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

The events of the past few weeks in Israel and Gaza, with all the tragic loss of life, are paralleled by another war—a war of words in the public arena reflecting political and ideological loyalties of those who are with, and those who are against. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
Samir N. Khleif, MD
Biomedical scholar & professor, Director, Center for Advanced Immunotherapy Research, Georgetown University
Raphael E. Pollock, MD, PhD
Director, The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital, Professor, Division of Surgical Oncology, The Ohio State University, Kathleen Wellenreiter Klotz Chair in Cancer Research, Director, Ohio State Sarcoma Research Laboratory
Robert A. Winn, MD
Director and Lipman Chair in Oncology, VCU Massey Comprehensive Cancer Center, Senior associate dean for cancer innovation, Professor of pulmonary disease and critical care medicine, VCU School of Medicine
Table of Contents

YOU MAY BE INTERESTED IN

Suspensions, public outrage ensue as tensions over Middle East sweep through oncology
NYU Cancer Center Director Benjamin Neel suspended over social media posts

Benjamin G. Neel, a widely respected cancer biologist with a considerable social media presence, was suspended from his job as director of the New York University Perlmutter Cancer Center following complaints over his retweets of political cartoons and other materials that were critical of protesters against Israel’s strikes on Gaza and that included caricatures critics described as “anti-Arab.”
By Paul Goldberg
Byline
Samir N. Khleif, MD
Biomedical scholar & professor, Director, Center for Advanced Immunotherapy Research, Georgetown University
Raphael E. Pollock, MD, PhD
Director, The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital, Professor, Division of Surgical Oncology, The Ohio State University, Kathleen Wellenreiter Klotz Chair in Cancer Research, Director, Ohio State Sarcoma Research Laboratory
Robert A. Winn, MD
Director and Lipman Chair in Oncology, VCU Massey Comprehensive Cancer Center, Senior associate dean for cancer innovation, Professor of pulmonary disease and critical care medicine, VCU School of Medicine
Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account